Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway

201414 citationsJournal Article

Authors

Mi-Heon Lee · University of California, Los Angeles

Abstract

Combined apricoxib and IL-27 has an enhanced effect in inhibition of epithelial-mesenchymal transition and cell migration in human lung cancer cells through a STAT1 dominant pathway.

Topics & Keywords

Cytokine Signaling Pathways and Interactions Inflammatory mediators and NSAID effects Immune cells in cancer

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Cancer Science & Therapy

Volume 06, Issue 11, pp. 468-477

DOI: 10.4172/1948-5956.1000310

Field-Weighted Citation Impact: 0.74